共有 50 笔近期内部人交易记录记录，涉及 Catalent, Inc. (CTLT), 包括 18 笔买入 和 32 笔卖出. 内部人买入总额为 RSU 奖励 内部人卖出总额为 $11.65M.
近期活跃的重要内部人包括 Stahl Jack L, Classon Rolf A, Damelio Frank A. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — CTLT
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2024-12-18 |
Stahl Jack L |
Director |
股份退回 |
47,984 |
- |
- |
- |
| 2024-12-18 |
Classon Rolf A |
Director |
股份退回 |
47,984 |
- |
- |
- |
| 2024-12-18 |
Damelio Frank A |
Director |
股份退回 |
12,635 |
- |
- |
- |
| 2024-12-18 |
Morel Donald E Jr |
Director |
股份退回 |
70,118 |
- |
- |
- |
| 2024-12-18 |
Lucier Gregory T |
Director |
股份退回 |
36,914 |
- |
- |
- |
| 2024-12-18 |
Greisch John J |
Executive Chair |
股份退回 |
127,096 |
$48.98 |
$6.23M |
- |
| 2024-12-18 |
Carroll J Martin |
Director |
股份退回 |
32,734 |
- |
- |
- |
| 2024-12-18 |
Masanovich Matti |
SVP, Chief Financial Officer |
股份退回 |
81,082 |
$44.76 |
$3.63M |
- |
| 2024-12-18 |
Gennadios Aristippos |
Group Pres. Pharma & Consumer |
股份退回 |
21,562 |
- |
- |
- |
| 2024-12-18 |
Evoli Lisa |
SVP, Chief HR Officer |
股份退回 |
12,032 |
- |
- |
- |
| 2024-12-18 |
Maselli Alessandro |
President & CEO |
股份退回 |
113,224 |
- |
- |
- |
| 2024-12-18 |
Gunther Scott |
SVP, Quality & Reg. Affairs |
股份退回 |
12,938 |
- |
- |
- |
| 2024-12-18 |
Ferraro Joseph Anthony |
SVP, General Counsel, Cco |
股份退回 |
14,265 |
- |
- |
- |
| 2024-12-18 |
Okey Stephanie |
Director |
股份退回 |
12,635 |
- |
- |
- |
| 2024-12-18 |
Hatzfeld Michael |
Chief Accounting Officer |
股份退回 |
3,144 |
- |
- |
- |
| 2024-12-18 |
Barg Steven |
Director |
股份退回 |
12,374 |
- |
- |
- |
| 2024-12-18 |
Barber Michael J |
Director |
股份退回 |
18,052 |
- |
- |
- |
| 2024-12-18 |
Hopson Ricky |
Pres. Bioproduct Delivery, Cos |
股份退回 |
10,669 |
$46.51 |
$496.22K |
- |
| 2024-12-18 |
Ryan Michelle R |
Director |
股份退回 |
10,835 |
- |
- |
- |
| 2024-12-18 |
Mcerlane David |
Group President, Biologics |
股份退回 |
11,426 |
- |
- |
- |
| 2024-11-11 |
Ryan Michelle R |
Director |
知情卖出 |
2,800 |
$59.70 |
$167.16K |
10,835 |
| 2024-10-30 |
Stahl Jack L |
Director |
限制性股票授予 (RSU) |
4,663 |
- |
- |
47,984 |
| 2024-10-30 |
Classon Rolf A |
Director |
限制性股票授予 (RSU) |
4,663 |
- |
- |
47,984 |
| 2024-10-30 |
Damelio Frank A |
Director |
限制性股票授予 (RSU) |
4,663 |
- |
- |
12,635 |
| 2024-10-30 |
Morel Donald E Jr |
Director |
限制性股票授予 (RSU) |
4,663 |
- |
- |
70,118 |
| 2024-10-30 |
Lucier Gregory T |
Director |
限制性股票授予 (RSU) |
4,663 |
- |
- |
36,914 |
| 2024-10-30 |
Carroll J Martin |
Director |
限制性股票授予 (RSU) |
4,663 |
- |
- |
32,734 |
| 2024-10-30 |
Okey Stephanie |
Director |
限制性股票授予 (RSU) |
4,663 |
- |
- |
12,635 |
| 2024-10-30 |
Barg Steven |
Director |
限制性股票授予 (RSU) |
4,663 |
- |
- |
12,374 |
| 2024-10-30 |
Barber Michael J |
Director |
限制性股票授予 (RSU) |
4,663 |
- |
- |
18,052 |
| 2024-10-30 |
Ryan Michelle R |
Director |
限制性股票授予 (RSU) |
4,663 |
- |
- |
13,635 |
| 2024-10-18 |
Ferraro Joseph Anthony |
SVP, General Counsel, Cco |
知情卖出 |
320 |
$59.97 |
$19.19K |
23,967 |
| 2024-09-26 |
Mcerlane David |
Group President, Biologics |
知情卖出 |
1,994 |
$59.97 |
$119.58K |
36,304 |
| 2024-08-02 |
Gennadios Aristippos |
Group Pres. Pharma & Consumer |
知情卖出 |
1,169 |
$59.55 |
$69.61K |
113,724 |
| 2024-08-02 |
Evoli Lisa |
SVP, Chief HR Officer |
知情卖出 |
3,859 |
$59.67 |
$230.27K |
39,366 |
| 2024-08-02 |
Gunther Scott |
SVP, Quality & Reg. Affairs |
知情卖出 |
666 |
$59.55 |
$39.66K |
39,635 |
| 2024-08-02 |
Ferraro Joseph Anthony |
SVP, General Counsel, Cco |
知情卖出 |
608 |
$59.58 |
$36.22K |
24,287 |
| 2024-08-02 |
Hopson Ricky |
Pres. Bioproduct Delivery, Cos |
知情卖出 |
662 |
$59.56 |
$39.43K |
29,974 |
| 2024-07-29 |
Gennadios Aristippos |
Group Pres. Pharma & Consumer |
知情卖出 |
349 |
$58.70 |
$20.49K |
114,893 |
| 2024-07-29 |
Maselli Alessandro |
President & CEO |
知情卖出 |
9,088 |
$58.76 |
$534.01K |
177,521 |
| 2024-07-29 |
Gunther Scott |
SVP, Quality & Reg. Affairs |
知情卖出 |
283 |
$58.69 |
$16.61K |
40,301 |
| 2024-07-29 |
Hopson Ricky |
Pres. Bioproduct Delivery, Cos |
知情卖出 |
206 |
$58.67 |
$12.09K |
30,636 |
| 2024-07-26 |
Greisch John J |
Executive Chair |
限制性股票授予 (RSU) |
63,736 |
- |
- |
79,932 |
| 2024-07-26 |
Masanovich Matti |
SVP, Chief Financial Officer |
限制性股票授予 (RSU) |
42,604 |
- |
- |
76,475 |
| 2024-07-26 |
Gennadios Aristippos |
Group Pres. Pharma & Consumer |
限制性股票授予 (RSU) |
18,746 |
- |
- |
115,242 |
| 2024-07-26 |
Evoli Lisa |
SVP, Chief HR Officer |
限制性股票授予 (RSU) |
15,338 |
- |
- |
43,225 |
| 2024-07-26 |
Maselli Alessandro |
President & CEO |
限制性股票授予 (RSU) |
98,671 |
- |
- |
186,609 |
| 2024-07-26 |
Gunther Scott |
SVP, Quality & Reg. Affairs |
限制性股票授予 (RSU) |
11,078 |
- |
- |
40,584 |
| 2024-07-26 |
Ferraro Joseph Anthony |
SVP, General Counsel, Cco |
限制性股票授予 (RSU) |
17,042 |
- |
- |
24,895 |
| 2024-07-26 |
Hatzfeld Michael |
Chief Accounting Officer |
限制性股票授予 (RSU) |
5,624 |
- |
- |
13,532 |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
